Alkaloid AD SkopjeXMAE:ALK -2.98%100 PS Ratio is 1.53 as of Jul. 09, 2026, which is 4% below its 10-year median of 1.60. GuruFocus rates XMAE:ALK with a GF Score™ of 100/100 and a GF Value™ of MKD27,289.88 (Modestly Undervalued). Among 952 Drug Manufacturers companies, Alkaloid AD Skopje ranks better than 63.45% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Alkaloid AD Skopje's share price is MKD22800.00.
Alkaloid AD Skopje's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MKD14,865.16. Hence, Alkaloid AD Skopje's PS Ratio for today is 1.53.
Good Sign:
Alkaloid AD Skopje stock PS Ratio (=1.58) is close to 5-year low of 1.54.
The historical rank and industry rank for Alkaloid AD Skopje's PS Ratio or its related term are showing as below:
XMAE:ALK'
s PS Ratio Range Over the Past 10 Years
Min: 0.89 Med: 1.6 Max: 2.31
Current: 1.53
During the past 13 years, Alkaloid AD Skopje's highest PS Ratio was 2.31. The lowest was 0.89. And the median was 1.60.
XMAE:ALK's PS Ratio is ranked better than 63.45% of 952
companies
in the Drug Manufacturers industry
Industry Median: 2.265
vs XMAE:ALK: 1.53
Alkaloid AD Skopje has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Alkaloid AD Skopje was 8.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 10.50% per year.
During the past 13 years, Alkaloid AD Skopje's highest 3-Year average Revenue per Share Growth Rate was 14.00% per year. The lowest was 3.30% per year. And the median was 8.30% per year.
Back to Basics: PS Ratio
Alkaloid AD Skopje (XMAE:ALK) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Alkaloid AD Skopje PS Ratio Related Terms
Alkaloid AD Skopje PS Ratio Historical Data
* Premium members only.
The historical data trend for Alkaloid AD Skopje's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkaloid AD Skopje PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's PS Ratio distribution charts can be found below:
* The bar in red indicates where Alkaloid AD Skopje's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Alkaloid AD Skopje's Share Price of today is MKD22800.00. Alkaloid AD Skopje's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD14,865.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Alkaloid AD Skopje (XMAE:ALK) has a PS Ratio of 1.53 as of Jul. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Alkaloid AD Skopje and its competitors. This is near median its historical median of 1.60. Over the past decade, Alkaloid AD Skopje's PS Ratio has ranged from 0.89 to 2.31. According to the industry distribution chart, Alkaloid AD Skopje ranks #348 out of 952 companies in the Drug Manufacturers industry, placing it in the top 36.6%.
Is Alkaloid AD Skopje's PS Ratio too high?
Alkaloid AD Skopje's current PS Ratio of 1.53 is near median its 10-year median of 1.60. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 2.31. The Drug Manufacturers industry median PS Ratio is 2.27. Alkaloid AD Skopje's value of 1.53 is 32.5% below this industry median. Based on the distribution chart, Alkaloid AD Skopje ranks #348 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Alkaloid AD Skopje has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkaloid AD Skopje ranks #348 out of 952 companies for PS Ratio. This puts Alkaloid AD Skopje in the upper half of its industry. The industry median PS Ratio is 2.27. Alkaloid AD Skopje's value of 1.53 is 32.5% below this benchmark. Historically, Alkaloid AD Skopje's own PS Ratio has ranged from 0.89 to 2.31 over the past decade. While the company's 10-year median is 1.60 vs. the industry median of 2.27, Alkaloid AD Skopje has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.27, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alkaloid AD Skopje's current PS Ratio of 1.53 is 32.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Alkaloid AD Skopje and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkaloid AD Skopje's current PS Ratio is 1.53, which is near median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,289.88, compared to a current price of MKD22,800.00 — trading 16.5% below its estimated fair value. The current PS Ratio is 1.53, which is near median its 10-year median of 1.60 and 32.5% below the Drug Manufacturers industry median of 2.27. Alkaloid AD Skopje's overall GF Score™ is 100/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current PS Ratio is 1.53 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?
Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued.
The current stock price of MKD22,800.00 is trading 16.5% below its estimated GF Value™ of MKD27,289.88.
GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.
Key valuation signals for XMAE:ALK:
PS Ratio: 1.53 (near median its 10-year median of 1.60)
GF Value™: MKD27,289.88 vs. price of MKD22,800.00 (16.5% below fair value)
Industry Position: 32.5% below the Drug Manufacturers median (#348 of 952)
No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
100GF Score
Get the complete analysis for XMAE:ALK
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAE:ALK has been successfully added to your 
